Vice President & Head of Neuroscience Portfolio Strategy & Alliances

Role: Vice President & Head of Neuroscience Portfolio Strategy & Alliances at Bristol Myers Squibb, responsible for shaping and integrating the neuroscience portfolio across neuropsychiatry, dementia, and neurodegenerative diseases. Responsibilities include developing strategic priorities, optimizing asset and indication choices, external partnerships, and enterprise positioning; leading external narrative and scientific engagement; overseeing global congress strategies; and managing strategic alliances and public-private partnerships. The role entails cross-functional collaboration with Medical, R&D, Commercial, and Business Development teams, ensuring portfolio decisions align with scientific opportunity and patient needs. Qualifications: Advanced degree (MD, PhD, PharmD) with 15+ years in biotech/pharma, leadership in portfolio strategy, neuroscience R&D, or alliances; deep understanding of neuroscience drug development, clinical, regulatory, and commercial landscapes; proven experience in portfolio decision-making, external collaborations, and enterprise strategy; strong leadership, communication, and stakeholder management skills. HighValue: Focus on neuroscience, neuropsychiatry, dementia, neurodegeneration, global strategy, external partnerships, scientific narrative, and high-visibility congress oversight. WorkSetup: On-site in Princeton Pike, NJ, with leadership responsibilities requiring strategic and cross-functional engagement.